176 related articles for article (PubMed ID: 11165595)
1. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).
Krause TG; Christens P; Wohlfahrt J; Lei U; Westergaard T; Nørgaard-Pedersen B; Melbye M
Obstet Gynecol; 2001 Feb; 97(2):277-82. PubMed ID: 11165595
[TBL] [Abstract][Full Text] [Related]
2. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies.
Buckland CM; Thom H; Campbell AG
J Perinat Med; 1984; 12(3):127-32. PubMed ID: 6209381
[TBL] [Abstract][Full Text] [Related]
4. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
5. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
7. Very low second-trimester maternal serum alpha-fetoprotein: Association with high birth weight.
Baschat AA; Harman CR; Farid G; Chodirker BN; Evans JA
Obstet Gynecol; 2002 Apr; 99(4):531-6. PubMed ID: 12039105
[TBL] [Abstract][Full Text] [Related]
8. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
[TBL] [Abstract][Full Text] [Related]
9. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
10. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
[TBL] [Abstract][Full Text] [Related]
11. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
[TBL] [Abstract][Full Text] [Related]
13. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
14. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
15. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels.
Puntachai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
Arch Gynecol Obstet; 2015 Jul; 292(1):81-5. PubMed ID: 25547063
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
17. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein.
Yetman DL; Kutteh WH; Castorena R; Brown C; Baskin L
J Reprod Immunol; 1997 Apr; 33(1):71-81. PubMed ID: 9185078
[TBL] [Abstract][Full Text] [Related]
19. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
Haddow JE; Knight GJ; Kloza EM; Palomaki GE
Br J Obstet Gynaecol; 1986 Jun; 93(6):589-93. PubMed ID: 2425844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
